Viewing Study NCT02527005


Ignite Creation Date: 2025-12-25 @ 3:11 AM
Ignite Modification Date: 2026-02-25 @ 5:51 PM
Study NCT ID: NCT02527005
Status: COMPLETED
Last Update Posted: 2017-12-11
First Post: 2015-08-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ Patients
Sponsor: University of Ibadan
Organization:

Study Overview

Official Title: A Comparative Study of Azithromycin and Sulphadoxine-pyrimethamine as Prophylaxis Against Malaria in Pregnant HIV Positive Patients
Status: COMPLETED
Status Verified Date: 2017-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Randomized controlled single blind prospective comparative study
Detailed Description: This study is intended to be a randomized controlled single blind prospective comparative study conducted to compare the efficacy of three monthly doses of sulphadoxine-pyrimethamine as intermittent preventive therapy for malaria with azithromycin in HIV positive pregnant women

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: